What is ulcerative colitis? (Letter) Lancet, 2, 254.Brooke, BN (1970) What is ulcerative colitis?. Lancet 1: pp. 1220-1220Goligher, J. C. (1953). What is ulcerative colitis? (Letter)Lancet,2,38.Brooke BN. (1953) What is ulcerative colitis? Lancet 1:1220–1225...
Ulcerative colitis is an idiopathic, chronic inflammatory disorder of the colonic mucosa, which starts in the rectum and generally extends proximally in a continuous manner through part of, or the entire, colon; however, some patients with proctitis or left-sided colitis might have a caecal patch...
Ulcerative colitis 溃疡性结肠炎 相关领域 溃疡性结肠炎医学炎症性肠病遗传倾向托法替尼胃肠病学结肠炎内科学免疫学疾病类风湿性关节炎 网址 https://doi.org/10.1016/s0140-6736(23)00966-2 DOI 10.1016/s0140-6736(23)00966-2doi 其它期刊:The Lancet ...
60% to 70% of ulcerative colitis patients are positive for perinuclear antineutrophil cytoplasmic antibodies (P-ANCA). P-ANCA is also found in a small number of patients with Crohn disease. In addition to P-ANCA, anti
Ulcerative colitis. Lancet 389, 1756–1770 (2016). Macpherson, A. J. & Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662–1665 (2004). Article CAS PubMed Google Scholar Peterson, D. A., McNulty, N. P., Guruge, J. L. ...
>Ulcerative colitis Ulcerative colitisUlcerative colitisOrdasI.EckmannL.TalaminiM.BaumgartD.C.SandborningentaconnectLancet London
What is ulcerative colitis? WHAT IS ULCERATIVE COLITIS ?. By - J.C. Goligher, J.M.Rice Oxley Hardy,L T. - 《Lancet》 被引量: 60发表: 1953年 Tofacitinib for the treatment of ulcerative colitis: A review of the literature Ulcerative colitis (UC) is a chronic immune-mediated inflammatory...
Differential diagnosis of chronic ulcerative colitis and Crohn’s disease of the colon - One, two or many diseases? In: Kirsner JB, ed. Inflammatory Bowel Disease, Fifth Edition. W. B. Saunders, Philadelphia, PA, 1999. Taraka M, Riddell RH, Saito H, et al. Morphologic criteria applicable...
Lancet 359, 1541–1549 (2002). CAS PubMed Google Scholar Rutgeerts, P. et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 353, 2462–2476 (2005). This study is the first phase III randomized, controlled clinical trial of an anti-TNF agent...
Skip to main contentSkip to article Journals & Books Help Search My accountSign in View PDF Download full issue Search ScienceDirect